Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122707323 | 12270732 | 3 | F | 20160312 | 20160628 | 20160415 | 20160701 | EXP | PHHY2016FR047146 | NOVARTIS | 64.00 | YR | F | Y | 0.00000 | 20160702 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122707323 | 12270732 | 1 | PS | ZOPHREN | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 8 MG, BID | 64 | MG | Y | 20007 | 8 | MG | BID | ||||
| 122707323 | 12270732 | 2 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 312 MG, QD | 624 | MG | Y | 0 | 312 | MG | QD | ||||
| 122707323 | 12270732 | 3 | SS | LEVACT | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 187 MG, QD | 374 | MG | 0 | 187 | MG | POWDER FOR SOL FOR INJ | QD | ||||
| 122707323 | 12270732 | 4 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 310 MG, QD (1 IN 1 SINGLE DOSE) | 310 | MG | 0 | 310 | MG | QD | |||||
| 122707323 | 12270732 | 5 | SS | INEXIUM//ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | Y | 0 | 40 | MG | QD | ||||||
| 122707323 | 12270732 | 6 | SS | EMEND | APREPITANT | 1 | Oral | 80 MG, QD | 320 | MG | Y | 0 | 80 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122707323 | 12270732 | 1 | Product used for unknown indication |
| 122707323 | 12270732 | 2 | T-cell lymphoma |
| 122707323 | 12270732 | 3 | T-cell lymphoma |
| 122707323 | 12270732 | 4 | T-cell lymphoma |
| 122707323 | 12270732 | 5 | Product used for unknown indication |
| 122707323 | 12270732 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122707323 | 12270732 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122707323 | 12270732 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122707323 | 12270732 | 1 | 20160309 | 20160313 | 0 | |
| 122707323 | 12270732 | 2 | 20160311 | 20160312 | 0 | |
| 122707323 | 12270732 | 3 | 20160309 | 20160310 | 0 | |
| 122707323 | 12270732 | 4 | 20160311 | 20160311 | 0 | |
| 122707323 | 12270732 | 5 | 20160308 | 0 | ||
| 122707323 | 12270732 | 6 | 20160309 | 20160312 | 0 |